Outsourced Compounding Usage Trends

January 2021 - Vol.18 No. 1 - Page #24
Category: Outsourced Compounding Services (503B)
 

While the FDA continues to issue 483s to 503B facilities, hospital pharmacies report a significant reduction over the last year in quality problems such as mislabeled or wrong volume products received from their vendors. Just 9% of pharmacies have experienced a recent quality problem with their vendor. While most hospital pharmacies are confident in the corrective action plans their vendor has implemented in response to any quality problems, a notable 22% are not satisfied with their vendor’s plan.


Over the past year, CAPS, Nephron, QuVa, and SCA Pharma have become the leading outsourced compounding vendors.

Click here to view a larger version of this Figure

Login

Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Current Issue